Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung cancer screening.

Mylene T Truong1, Reginald F Munden

  • 1Division of Diagnostic Imaging, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Box 0057, Houston, TX 77030, USA. mtruong@di.mdacc.tmc.edu

Current Oncology Reports
|June 5, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Photon-counting CT in cardiac imaging: multi-institutional guidance on technical principles, clinical evidence, and practical protocols.

European journal of radiology·2026
Same author

Uncommon Spindle Cell Tumors of the Pleura.

Advances in anatomic pathology·2025
Same author

Pleural Mesothelioma: Ninth Edition of the TNM Staging Classification.

Radiology. Cardiothoracic imaging·2025
Same author

The Ninth Edition TNM Staging System for Thymic Epithelial Tumors: A Comprehensive Review.

Radiology. Cardiothoracic imaging·2025
Same author

Atypical Pulmonary Metastases: Patterns and Clinical Significance.

Radiographics : a review publication of the Radiological Society of North America, Inc·2025
Same author

Pulmonary Fungal Infections in a Tertiary Cancer Center: A Morphological Correlation of 160 Cases with CT and PET Imaging.

Diagnostics (Basel, Switzerland)·2025
Same journal

Revisiting the Immunological Landscape of Locoregional Therapies for Gastrointestinal Cancers: A Shift Toward Interventional Immuno-Oncology.

Current oncology reports·2026
Same journal

Anti-PD-1 Combinations: Triplets and Beyond.

Current oncology reports·2026
Same journal

Sacituzumab Tirumotecan Across Gynecologic Malignancies: One Target, Multiple Diseases.

Current oncology reports·2026
Same journal

Clusterin in Head and Neck Squamous Cell Carcinoma: Diagnostic, Prognostic, and Therapeutic Implications.

Current oncology reports·2026
Same journal

Cardiac Risk Without a Roadmap: Lack of Evidence-Based Guidance for Cardiovascular Toxicity of T-Cell Redirecting Therapies.

Current oncology reports·2026
Same journal

Current Understanding of CHIP's Immunobiological Footprint with A Focus on Gastrointestinal Disorders: A Review of the Literature.

Current oncology reports·2026
See all related articles

Low-dose computed tomography (CT) screening for lung cancer is debated. While CT technology has advanced, concerns about overdiagnosis and nodule detection rates persist, necessitating further research.

Area of Science:

  • Pulmonology
  • Radiology
  • Oncology

Background:

  • Lung cancer screening has evolved from chest radiography to helical computed tomography (CT).
  • The current standard for lung cancer screening involves helical multidetector CT.
  • Early screening methods in the 1970s utilized chest radiography.

Purpose of the Study:

  • To review the historical development of lung cancer screening trials.
  • To address the principles and confounding biases inherent in screening programs.
  • To discuss current concerns regarding overdiagnosis and nodule detection rates in low-dose CT screening.

Main Methods:

  • Review of historical lung cancer screening trials.
  • Analysis of principles and biases in screening.

Related Experiment Videos

  • Examination of results from prevalence and incidence studies.

    • Main Results:

    • Low-dose CT screening for lung cancer presents complexities and controversies.
    • Prevalence and single-arm incidence studies indicate potential overdiagnosis and high nodule detection rates.
    • Further follow-up studies and investigations are required to clarify screening efficacy.

    Conclusions:

    • The effectiveness and potential harms of low-dose CT lung cancer screening require continued investigation.
    • A National Cancer Institute-sponsored randomized, controlled trial is ongoing to assess disease-specific mortality.
    • Understanding screening principles and biases is crucial for interpreting study results.